FiercePharma

Novo’s Wegovy, J&J’s Tremfya step up TV ad spending amid March Madness tournament

Last year, AbbVie’s Skyrizi and Rinvoq were practically unshakeable atop the monthly TV drug ad spending rankings, ultimately leading the pair of immunology meds to take the full-year title for the ...
WebMD

Tremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and Crohn’s Disease

What Is Tremfya, and Why Does It Matter? Tremfya (guselkumab) is a lab-made, dual-acting antibody medication that reduces inflammation by targeting the interleukin-23 (IL-23) protein and blocking a ...
FiercePharma

TV drug ad spending picked up in September despite federal crackdown

Even as President Donald Trump directed the FDA in early September to begin cracking down on direct-to-consumer pharmaceutical advertising, spending on TV drug ads still ratcheted up compared to the ...